Bempedoic acid/Ezetimibe Prescribing at FITZALAN MEDICAL GROUP
Lipid-regulating drugs | Cardiovascular System
Items (12m)
163
Total Quantity
7,420
NHS Cost
£14.0K
vs National Avg
+166.9%
FITZALAN MEDICAL GROUP prescribed 163 items of Bempedoic acid/Ezetimibe over the last 12 months at a cost of £13,959 to the NHS. This is 166.9% above the national average prescribing rate. Bempedoic acid/Ezetimibe is classified under Lipid-regulating drugs in the BNF.
Monthly Prescribing Trend
Jul 2026
11
Jul 2026
7
Jul 2026
11
Jul 2026
8
Jul 2026
11
Jul 2026
15
Jul 2026
11
Jul 2026
17
Jul 2026
21
Jul 2026
14
Jul 2026
20
Jul 2026
17
Prescribing Details
| Total Items | 163 |
|---|---|
| Total Quantity | 7,420 |
| Total NHS Cost | £13,959 |
| Presentations | 1 different forms |
| vs National Average | +166.9% |
Bempedoic acid/Ezetimibe Prescribing Comparison
| This practice | 163 items |
|---|---|
| National average per practice | 61 items |
| Difference | +166.9% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.